Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | ACHE | P22303 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | BCHE | P06276 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | TEAD4 | Q15561 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | WDR5 | P61964 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4530562 | 0.87 | RAB9A (0.35) | LMNAALDH1A1MAPTTDP1KMT2A | |
| SCHEMBL11956141 | 0.84 | LMNA (0.56) | LMNAACHEALDH1A1GAAMAPT | |
| SCHEMBL13577644 | 0.81 | ESR2 (0.44) | LMNAACHEALDH1A1GAAMAPT | |
| SCHEMBL9169744 | 0.81 | CA1 (0.52) | LMNAACHEALDH1A1GAAMAPT | |
| SCHEMBL2287929 | 0.80 | LMNA (0.56) | LMNAACHEALDH1A1GAAMAPT | |
| SCHEMBL12833374 | 0.80 | KMT2A (0.43) | ALDH1A1MAPTTDP1CYP3A4TSHR | |
| SCHEMBL12833375 | 0.80 | KIF11 (0.39) | LMNAGAAKDM4EKMT2AMEN1 | |
| SCHEMBL1505815 | 0.80 | KIF11 (0.39) | LMNAGAAKDM4EKMT2AMEN1 | |
| SCHEMBL8934991 | 0.80 | KIF11 (0.39) | LMNAGAAKDM4EKMT2AMEN1 | |
| SCHEMBL1505923 | 0.78 | MEN1 (0.48) | LMNAALDH1A1GAAMAPTKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230383186-A1 | LIQUID-CRYSTAL MEDIUM | MERCK PATENT GMBH (DE) | 2023-11-30 | — | — | US | disclosed |
| US-10000700-B2 | Nematic liquid crystal composition | DIC CORPORATION (JP) | 2018-06-19 | — | — | US | disclosed |
| EP-2797871-B1 | CROSSLINKABLE ARYLAMINE COMPOUNDS | NISSAN CHEMICAL IND LTD (JP) | 2018-05-09 | — | — | EP | disclosed |
| US-20170198219-A1 | NEMATIC LIQUID CRYSTAL COMPOSITION | DIC CORPORATION (JP) | 2017-07-13 | — | — | US | disclosed |
| US-20150094437-A1 | CROSSLINKABLE ARYLAMINE COMPOUNDS | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2015-04-02 | — | — | US | disclosed |
| US-20150094437-A1 | CROSSLINKABLE ARYLAMINE COMPOUNDS | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2015-04-02 | — | — | US | disclosed |
| US-8921358-B2 | Apoptosis signal-regulating kinase 1 inhibitors | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2014-12-30 | — | — | US | disclosed |
| US-8921358-B2 | Apoptosis signal-regulating kinase 1 inhibitors | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2014-12-30 | — | — | US | disclosed |
| US-8580401-B2 | Curable material and its application | ETERNAL CHEMICAL CO., LTD. (TW) | 2013-11-12 | — | — | US | disclosed |
| US-20130203731-A1 | APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (US) | 2013-08-08 | — | — | US | disclosed |
| WO-2010082924-A1 | CROSS-LINKABLE COPPER PHTHALOCYANINE COMPLEXES | UNIVERSAL DISPLAY CORPORATION (US) | 2010-07-22 | — | — | WO | disclosed |
| WO-2010068205-A1 | CROSS LINKED ORGANIC CONDUCTIVE LAYER | HCF PARTNERS, L.P. (US) | 2010-06-17 | — | — | WO | disclosed |
| WO-2010059646-A2 | AMINOBENZENE COMPOSITIONS AND RELATED DEVICES AND METHODS | PLEXTRONICS, INC. (US) | 2010-05-27 | — | — | WO | disclosed |
| US-20090192263-A1 | TRIFLUOROVINYL AROMATIC CONTAINING POLY(ALKYL ETHER) PREPOLYMERS | BAUSCH & LOMB MEXICO, S.A. DE C.V. (MX) | 2009-07-30 | — | — | US | disclosed |
| US-7538160-B2 | Trifluorovinyl aromatic containing poly(alkyl ether) prepolymers | BAUSCH & LOMB INCORPORATED (US) | 2009-05-26 | — | — | US | disclosed |
| US-7402634-B2 | Perfluorocyclobutane copolymers | BAUSCH AND LAMB INCORPORATED (US) | 2008-07-22 | — | — | US | disclosed |
| US-20070154429-A1 | PERFLUOROCYCLOBUTANE CROSSLINKED HYDROGELS | ZIMMER, INC. (US) | 2007-07-05 | — | — | US | disclosed |
| US-7214475-B2 | Partially polymerizing a blend of a bis(trifluorovinyl) derivative of a group of a group 14 metal (especially Si or Ge) compound, another bis(trifluorovinyl) compound, a photocurable compound and a photoinitiator; depositing product on a substrate; exposing to effect photocuring; and curing the product | MOMENTIVE PERFORMANCE MATERIALS INC. | 2007-05-08 | — | — | US | disclosed |
| US-7214475-B2 | Partially polymerizing a blend of a bis(trifluorovinyl) derivative of a group of a group 14 metal (especially Si or Ge) compound, another bis(trifluorovinyl) compound, a photocurable compound and a photoinitiator; depositing product on a substrate; exposing to effect photocuring; and curing the product | MOMENTIVE PERFORMANCE MATERIALS INC. | 2007-05-08 | — | — | US | disclosed |
| US-20070004897-A1 | Trifluorovinyl aromatic containing poly(alkyl ether) prepolymers | BAUSCH & LOMB INCORPORATED | 2007-01-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130203731-A1 | APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS | BAX, BCL2, BAD | LMNA 1347/4885ACHE 4638/4885ALDH1A1 2965/4885 |
| US-20070154429-A1 | PERFLUOROCYCLOBUTANE CROSSLINKED HYDROGELS | SYVN1, EPHA2, FGFR2 | LMNA 4355/4885ACHE 2873/4885ALDH1A1 904/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.